Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-23-006324

Options or other derivatives

  • Chief Executive Officer acquired 453,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Gros David-Alexandre C Chief Executive Officer 2023-02-01 Grant or award · Stock Option (right to buy) +300,000 300,000 D
Gros David-Alexandre C Chief Executive Officer 2023-02-01 Grant or award · Stock Option (right to buy) +153,600 153,600 D
Loading xslF345X03/doc4.xml…